Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NSAIDs + analgesics refers to the combination of nonsteroidal anti-inflammatory drugs (NSAIDs) with other analgesic agents, most commonly acetaminophen or opioid/non-opioid pain relievers. This combination is used to enhance pain relief by targeting different mechanisms in the body. NSAIDs, such as ibuprofen and naproxen, inhibit cyclooxygenase (COX) enzymes involved in prostaglandin synthesis, thereby reducing inflammation and peripheral pain signaling. Analgesics like acetaminophen act primarily within the central nervous system to block pain transmission. When combined, these drugs provide additive or synergistic effects for managing mild to moderate pain and are often more effective than either agent alone[6][5]. Common indications include acute dental pain, musculoskeletal injuries, arthritis, and postoperative discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NSAIDs + analgesics.